Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer.

Huggett MT, Jermyn M, Gillams A, Illing R, Mosse S, Novelli M, Kent E, Bown SG, Hasan T, Pogue BW, Pereira SP.

Br J Cancer. 2014 Apr 2;110(7):1698-704. doi: 10.1038/bjc.2014.95. Epub 2014 Feb 25.

2.

Photodynamic therapy using verteporfin photosensitization in the pancreas and surrounding tissues in the Syrian golden hamster.

Ayaru L, Wittmann J, Macrobert AJ, Novelli M, Bown SG, Pereira SP.

Pancreatology. 2007;7(1):20-7. Epub 2007 Apr 18.

PMID:
17449962
3.

Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.

Opitz I, Krueger T, Pan Y, Altermatt HJ, Wagnières G, Ris HB.

Eur Surg Res. 2006;38(3):333-9. Epub 2006 Jun 19.

PMID:
16785733
4.

Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).

Mikvy P, Messman H, MacRobert AJ, Pauer M, Sams VR, Davies CL, Stewart JC, Bown SG.

Br J Cancer. 1997;76(6):713-8.

5.

Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.

Lui H, Hobbs L, Tope WD, Lee PK, Elmets C, Provost N, Chan A, Neyndorff H, Su XY, Jain H, Hamzavi I, McLean D, Bissonnette R.

Arch Dermatol. 2004 Jan;140(1):26-32.

PMID:
14732656
6.

Photodynamic therapy for pancreatic cancer.

Fan BG, Andrén-Sandberg A.

Pancreas. 2007 May;34(4):385-9. Review.

PMID:
17446835
7.

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Celli JP, Solban N, Liang A, Pereira SP, Hasan T.

Lasers Surg Med. 2011 Sep;43(7):565-74. doi: 10.1002/lsm.21093.

8.

Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus.

Panjehpour M, DeNovo RC, Petersen MG, Overholt BF, Bower R, Rubinchik V, Kelly B.

Lasers Surg Med. 2002;30(1):26-30.

PMID:
11857600
9.

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488.

PMID:
10496389
10.

Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

Chen B, Pogue BW, Zhou X, O'Hara JA, Solban N, Demidenko E, Hoopes PJ, Hasan T.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):720-7.

11.

Photodynamic therapy for cancer of the pancreas.

Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, Jones L, Wyld P, Gillams A, Hatfield AW.

Gut. 2002 Apr;50(4):549-57.

12.

Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter.

Choi JH, Oh D, Lee JH, Park JH, Kim KP, Lee SS, Lee YJ, Lim YS, Song TJ, Lee SS, Seo DW, Lee SK, Kim MH, Park DH.

Endoscopy. 2015 Nov;47(11):1035-8. doi: 10.1055/s-0034-1392150. Epub 2015 Jun 12.

PMID:
26070006
13.

CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy.

Jermyn M, Davis SC, Dehghani H, Huggett MT, Hasan T, Pereira SP, Bown SG, Pogue BW.

Phys Med Biol. 2014 Apr 21;59(8):1911-21. doi: 10.1088/0031-9155/59/8/1911. Epub 2014 Mar 20.

14.

Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.

Blasi MA, Tiberti AC, Scupola A, Balestrazzi A, Colangelo E, Valente P, Balestrazzi E.

Ophthalmology. 2010 Aug;117(8):1630-7. doi: 10.1016/j.ophtha.2009.12.033. Epub 2010 Apr 24.

PMID:
20417564
15.

EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video).

Yusuf TE, Matthes K, Brugge WR.

Gastrointest Endosc. 2008 May;67(6):957-61. doi: 10.1016/j.gie.2007.08.020. Epub 2008 Feb 21.

PMID:
18178203
16.

Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Verigos K, Stripp DC, Mick R, Zhu TC, Whittington R, Smith D, Dimofte A, Finlay J, Busch TM, Tochner ZA, Malkowicz S, Glatstein E, Hahn SM.

J Environ Pathol Toxicol Oncol. 2006;25(1-2):373-87.

PMID:
16566729
17.

Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma.

Jurklies B, Anastassiou G, Ortmans S, Schüler A, Schilling H, Schmidt-Erfurth U, Bornfeld N.

Br J Ophthalmol. 2003 Jan;87(1):84-9.

19.

Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer.

Yano T, Muto M, Yoshimura K, Niimi M, Ezoe Y, Yoda Y, Yamamoto Y, Nishisaki H, Higashino K, Iishi H.

Radiat Oncol. 2012 Jul 23;7:113. doi: 10.1186/1748-717X-7-113.

20.

Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.

Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW.

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2384-91.

PMID:
12091441

Supplemental Content

Support Center